-
EP3972633
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3972633
| EP3972633 - ANTI-ABETA VACCINE THERAPY [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 01.09.2023 Database last updated on 26.07.2024 | |
| Former | Request for examination was made Status updated on 25.02.2022 | ||
| Former | The international publication has been made Status updated on 27.11.2020 | ||
| Former | unknown Status updated on 27.05.2020 | Most recent event Tooltip | 23.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states AC Immune SA EPFL Innovation Park Building B 1015 Lausanne / CH | [2022/13] | Inventor(s) | 01 /
PFEIFER, Andrea c/o AC Immune SA, EPFL Innovation Park, Building B 1015 Lausanne / CH | 02 /
MUHS, Andreas deceased / CH | [2022/13] | Representative(s) | Boult Wade Tennant LLP Salisbury Square House 8 Salisbury Square London EC4Y 8AP / GB | [2022/13] | Application number, filing date | 20726473.0 | 20.05.2020 | [2022/13] | WO2020EP64172 | Priority number, date | EP20190175810 | 21.05.2019 Original published format: EP 19175810 | EP20190185593 | 10.07.2019 Original published format: EP 19185593 | EP20200171549 | 27.04.2020 Original published format: EP 20171549 | EP20200172205 | 29.04.2020 Original published format: EP 20172205 | [2022/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020234405 | Date: | 26.11.2020 | Language: | EN | [2020/48] | Type: | A1 Application with search report | No.: | EP3972633 | Date: | 30.03.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.11.2020 takes the place of the publication of the European patent application. | [2022/13] | Search report(s) | International search report - published on: | EP | 26.11.2020 | Classification | IPC: | A61K39/00, A61P25/00, A61P25/28 | [2022/13] | CPC: |
A61K39/0007 (EP,IL,KR,US);
A61K39/39 (US);
A61P25/00 (EP,IL,KR);
A61P25/28 (EP,IL,KR,US);
A61K2039/54 (KR);
A61K2039/545 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/13] | Title | German: | ANTI-ABETA IMPFSTOFFTHERAPIE | [2022/13] | English: | ANTI-ABETA VACCINE THERAPY | [2022/13] | French: | VACCINOTHÉRAPIE ANTI-ABÊTA | [2022/13] | Entry into regional phase | 11.11.2021 | National basic fee paid | 11.11.2021 | Designation fee(s) paid | 11.11.2021 | Examination fee paid | Examination procedure | 11.11.2021 | Examination requested [2022/13] | 11.11.2021 | Date on which the examining division has become responsible | 12.07.2022 | Amendment by applicant (claims and/or description) | 05.09.2023 | Despatch of a communication from the examining division (Time limit: M04) | 15.01.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 28.03.2022 | Renewal fee patent year 03 | 23.03.2023 | Renewal fee patent year 04 | 22.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD]WO2007068411 (AC IMMUNE SA [CH], et al) [YD] 1-36 *** page 65, claims 4, 7, 14-19, 21, 85 ***; | [YD]WO2013044147 (AC IMMUNE SA [US], et al) [YD] 1-36*** para, 9, 175, 186; claim 1; Figure 1 ***; | [YD] - MUHS ANDREAS ET AL, "Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, (20070605), vol. 104, no. 23, doi:10.1073/PNAS.0703137104, ISSN 0027-8424, pages 9810 - 9815, XP002542049 [YD] 1-36 *** pages 9810, 9813, 9814, Figure 1 *** DOI: http://dx.doi.org/10.1073/PNAS.0703137104 | [A] - FRANCES WISEMAN, "A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome", NATURE REVIEWS NEUROSCIENCE, (20150101), vol. 16, pages 564 - 574, XP055712026 [A] 1-36 *** Fig. 1 *** DOI: http://dx.doi.org/10.1038/nrn3983 | [YD] - PAVEL V. BELICHENKO ET AL, "An Anti-[beta]-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome", PLOS ONE, (20160329), vol. 11, no. 3, doi:10.1371/journal.pone.0152471, page e0152471, XP055711830 [YD] 1-36 *** pages 2, 3 *** DOI: http://dx.doi.org/10.1371/journal.pone.0152471 | by applicant | WO2005081872 | WO2007068411 | WO2012020124 | WO2012055933 | WO2013044147 | - O'BRYANT et al., Arch Neurol., (20100000), vol. 67, no. 6, pages 746 - 749 | - NASREDDINE ZSPHILLIPS NA et al., "The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment", J Am Geriatr Soc., (20050000), vol. 53, pages 695 - 699 | - BELICHENKO PVMADANI RREY-BELLET L et al., "An Anti-(3-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome", PLOS ONE, (20160000), vol. 11, no. 3, page e0152471 | - FOLSTEIN MFFOLSTEIN SEMCHUGH PR, "Mini-Mental State'': a practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, (19750000), vol. 12, pages 189 - 198 | - GILMAN S.KOLLER M.BLACK R.S.JENKINS L.GRIFFITH S.G.FOX N.C.EISNER L.KIRBY L., BOADA ROVIRA M.FORETTE F.ORGOGOZO J.M., "Clinical effect of Aβ immunization (AN1792) in patients with AD in an interrupted trial", Neurology, (20050000), vol. 64, doi:10.1212/01.WNL.0000159740.16984.3C, pages 1553 - 1562, XP008103962 DOI: http://dx.doi.org/10.1212/01.WNL.0000159740.16984.3C | - HARTLEY SLHANDEN BLDEVENNY D et al., "Cognitive decline and brain amyloid-13 accumulation across 3 years in adults with Down syndrome", Neurobiology of aging, (20170000), vol. 58, pages 68 - 76 | - HEAD EPOWELL DGOLD BTSCHMITT FA., "Alzheimer's Disease in Down Syndrome", European journal of neurodegenerative disease, (20120000), vol. 1, no. 3, pages 353 - 364 | - HUGHES CPBERG LDANZINGER WL et al., "A new clinical scale for the staging of dementia", Am J Psychiatry, (19820000), vol. 140, pages 566 - 572 | - MONSONEGO A.WEINER H.L., "Immunotherapeutic approaches to Alzheimer's disease", Science. 31, (20030000), vol. 302, no. 5646, doi:10.1126/science.1088469, pages 834 - 8, XP002316962 DOI: http://dx.doi.org/10.1126/science.1088469 | - MUHS A.HICKMAN D.T.PIHLGREN M.CHUARD N.GIRIENS V.MEERSCHMAN C.VAN DER AUWERA I.VAN LEUVEN F.SUGAWARA M.WEINGERTNER M.-C., "Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice", PNAS, (20070000), vol. 104, no. 23, doi:10.1073/PNAS.0703137104, pages 9810 - 9815, XP002542049 DOI: http://dx.doi.org/10.1073/PNAS.0703137104 | - ORGOGOZO J.M.GILMAN S.DARTIGUES J.F.LAURENT B.PUEL M.KIRBY L.C.JOUANNY P.DUBOIS B.EISNER L.FLITMAN S., "Subacute meningoencephalitis in a subset of patients with AD after Abet42 immunization", Neurology, (20030000), vol. 61, doi:10.1212/01.WNL.0000073623.84147.A8, pages 46 - 54, XP055642773 DOI: http://dx.doi.org/10.1212/01.WNL.0000073623.84147.A8 | - PRASHER VPHUXLEY AHAQUE MS, "A 24-week, doubleblind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease-pilot study", Int J Geriatr Psychiatry, (20020000), vol. 17, no. 3, pages 270 - 278 | - PIHLGREN M.SILVA A.B.MADANI R.GIRIENS V.WAECKERLE-MEN Y.FETTELSCHOSS A.HICKMAN D.T.LOPEZ-DEBER M.P.NDAO D.M.VUKICEVIC M., "TLR4-and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice", Blood, (20130103), vol. 121, no. 1, doi:10.1182/blood-2012-02-413831, pages 85 - 94, XP055552884 DOI: http://dx.doi.org/10.1182/blood-2012-02-413831 | - SOTO C., "Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease", Molecular Medicine Today, (19990800), vol. 5, doi:10.1016/S1357-4310(99)01508-7, XP000985704 DOI: http://dx.doi.org/10.1016/S1357-4310(99)01508-7 | - WINBLAD B.GRAF A.RIVIERE M.E.ANDREASEN N.RYAN J.M., "Active immunotherapy options for Alzheimer's disease", Alzheimers Res Ther., (20140130), vol. 6, no. 1, doi:10.1186/alzrt237, page 7, XP021196286 DOI: http://dx.doi.org/10.1186/alzrt237 |